The Indian government released its fiscal 2007–08 (starting April 1) budget on February 28. The budget contained favorable news for instrument companies and their customers. The annual budget for the Ministry of Science and Technology rose 46% to Rs3,271 ($74.0 million). Within the Ministry, the Department of Science and Technology received a 58% increase in […]
Fourth quarter 2006 IBO Life Science Index sales rose 8.7% to $2,124 million. Operating profit for the same period gained 2.8% to $343 million, a steep decline from the previous quarter’s operating profit growth of 19%. Operating margin slipped 110 basis points from 17.2% to 16.1% of revenues. Year-over-year Life Science Index sales increased 7.7% […]
Routine Becomes Commonplace Although advancing technology remains an important aspect of instrument companies’ product development and reputation, companies are putting greater emphasis on instrumentation for so-called routine applications, such as quality analysis and quality control testing, or other nonresearch applications. Many of the fastest growing markets, including food and beverage and metals testing, do not […]
Hopes were high for Pittcon this year. After all, the conference was returning to Chicago, Illinois following a two-year stint in Orlando, Florida. Although not as temperate as Florida, in 2004, Chicago had hosted a Pittcon attended by over 25,000, the highest attendance in past six years. Preliminary numbers as of February 28 show a […]
The fiscal 2007 federal budget was finally signed into law by President Bush on February 15. The law makes permanent most of the funding amounts in the continuing resolution passed by Congress in December 2006 that essentially froze agency and program budgets at fiscal 2006 levels. However, Congress did provide funding increases for selected programs […]
According to the FDA, 10% of drugs in the world are counterfeit. The World Health Organization (WHO) takes a more nuanced view: according to the organization, less than 1% of drugs in developed nations are counterfeit, but 10% of drugs in developing economies are counterfeit. However, in parts of Latin America, Southeast Asia and sub-Saharan […]
Major restructurings of R&D operations were announced earlier this year by two of the world’s largest pharmaceutical companies, Pfizer and Roche. Such announcements are becoming more common for so-called “big pharma” (see IBO 4/15/05, 4/15/06), as many of the world’s 10 largest drug firms struggle to maintain historical levels of profitability during a period of […]
While President Bush’s proposed budget for FY08 would increase the total federal R&D investment by 1.4% to $143.0 billion, federal support of basic and applied research would decline to $55.4 billion, a 2% drop from the FY07 budget. Not including NASA, the total budget increase for nondefense R&D agencies is only 0.8%, below the national […]
With 15 of the 23 Laboratory Instrument Sales Index companies reporting calendar year-end results, fourth quarter 2006 revenues grew an estimated 10.5% to $4,131 million. Fourth quarter operating profit growth rebounded from a year ago, improving 8.0% to $707 million. However, operating margin dropped 40 basis points to 17.1% of sales. The five largest instrument […]
Palm Springs, California’s desert air and sunny days were once again a perfect background for the Association for Laboratory Automation’s (ALA) annual LabAutomation conference. Held January 28–31 and accompanied by a three-day exhibition, the conference drew 4,600 registrants, a 9% increase from last year (see IBO 1/31/06). However, the number of exhibitors fell 15% to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
